BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Breast Cancer
,
Leukocyte
,
Early pregnancy factor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Activin types I and II receptor domain
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tonsil
Colon cecum
Bladder
Bone marrow
Ovary
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Alpha-1-antitrypsin deficiency
Vitamin D deficiency
Chlamydial infection
Antiphospholipid syndrome
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
IL7 protein, human
AST-1306
CGP 60474
GSK-1059615
niguldipine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
EBF3
MAMLD1
PPP2R2C
SMAD9
NANOS1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Livers of mice treated with genotoxic or non-genotoxic carcinogens
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Myeloid-derived suppressor cells in tumor-bearing mice - miRNA expression
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Activin types I and II receptor domain
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A0…
A Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Metastatic Breast Cance…
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-79…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ